75 related articles for article (PubMed ID: 1426658)
1. Prediction of pulmonary immunodeficiency in chronic bronchitis by cutaneous hypoergy to multitest.
Baglioni S; Dottorini M; Sini GM; Eslami A; Vecchiarelli A; Todisco T
Dev Biol Stand; 1992; 77():167-73. PubMed ID: 1426658
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
López M; Jerez J; González M; Arias M
Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
[TBL] [Abstract][Full Text] [Related]
3. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A.
Kniker WT; Anderson CT; McBryde JL; Roumiantzeff M; Lesourd B
Ann Allergy; 1984 Feb; 52(2):75-82. PubMed ID: 6696298
[TBL] [Abstract][Full Text] [Related]
4. Delayed skin hypersensitivity in man. The effect of repeated tests with low-dose antigen.
Merk K; Björkholm M; Holm G; Mellstedt H
Acta Derm Venereol; 1988; 68(5):450-3. PubMed ID: 2461034
[TBL] [Abstract][Full Text] [Related]
5. Serial delayed cutaneous hypersensitivity skin testing with multiple recall antigens in healthy volunteers: booster effect study.
Lesourd BM; Wang A; Moulias R
Ann Allergy; 1985 Nov; 55(5):729-35. PubMed ID: 4061981
[TBL] [Abstract][Full Text] [Related]
6. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
7. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
8. [Use of the "Multitest-CMI" in the evaluation of cutaneous delayed hypersensitivity reaction to antigens in patients with chronic diseases of the liver].
Juszczyk J; Barałkiewicz G; Bereszyńska I; Adamek J
Przegl Epidemiol; 1990; 44(4):285-92. PubMed ID: 2100810
[TBL] [Abstract][Full Text] [Related]
9. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
[TBL] [Abstract][Full Text] [Related]
10. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
[TBL] [Abstract][Full Text] [Related]
11. [Type IV immunity in alopecia areata in a comparison of 2 test methods].
Lutz G; Niedecken H; Bauer R; Kreysel HW
Z Hautkr; 1988 May; 63(5):391-2, 395-7. PubMed ID: 3261476
[TBL] [Abstract][Full Text] [Related]
12. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
13. Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases.
Budweiser S; Meyer K; Jörres RA; Heinemann F; Wild PJ; Pfeifer M
Eur J Clin Nutr; 2008 Mar; 62(3):436-43. PubMed ID: 17342162
[TBL] [Abstract][Full Text] [Related]
14. [The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease].
Soyyiğit S; Erk M; Güler N; Kilinç G
Tuberk Toraks; 2006; 54(3):259-66. PubMed ID: 17001544
[TBL] [Abstract][Full Text] [Related]
15. Dietary supplementation and immunocompetence in housebound elderly subjects.
Bunker VW; Stansfield MF; Deacon-Smith R; Marzil RA; Hounslow A; Clayton BE
Br J Biomed Sci; 1994 Jun; 51(2):128-35. PubMed ID: 8049610
[TBL] [Abstract][Full Text] [Related]
16. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
Ferguson MK; Vigneswaran WT
Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
[TBL] [Abstract][Full Text] [Related]
18. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.
Bobbio A; Chetta A; Carbognani P; Internullo E; Verduri A; Sansebastiano G; Rusca M; Olivieri D
Eur J Cardiothorac Surg; 2005 Nov; 28(5):754-8. PubMed ID: 16140541
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma (r-IFN-gamma) induced activation of alveolar macrophages (AM) from anergic patients with chronic obstructive pulmonary disease (COPD).
Todisco T; Vecchiarelli A; Dottorini M; Eslami A; Bertotto A; Massucci M; Crupi S; Cenci E; Arcangeli C; Fabietti PG
J Biol Regul Homeost Agents; 1992; 6(3):87-92. PubMed ID: 1492597
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous delayed hypersensitivity in a French reference population using the cell-mediated immunity multitest device].
Biron G; Roumiantzeff M; Ajjan N; Richard C; Tixier G; Serrou B
Ann Anesthesiol Fr; 1981; 22(3):270-8. PubMed ID: 6117233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
